All Stories

  1. Efficacy and safety of leflunomide with tumor necrosis factor inhibitors in psoriatic arthritis: a retrospective analysis

    Article • Clinical Rheumatology, July 2026, Springer Science + Business Media

    Emre Bilgin

  2. Comparison of Systemic Corticosteroid Therapy Practices Between Pediatric and Adult Rheumatologists: A Multicenter Survey Study

    Article • Rheumatology and Therapy, June 2026, Springer Science + Business Media

    Emre Bilgin

  3. Treatment response and retention rates of bDMARDs in advanced spinal ankylosis or bamboo spine: Real-world data from the HUR-BIO registry

    Article • Ulusal Romatoloji Dergisi, June 2026, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  4. Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project

    Article • Annals of the Rheumatic Diseases, June 2026, Elsevier

    Emre Bilgin

  5. Risk of intestinal involvement in mucocutaneous-onset Behçet’s disease: data from the AIDA network registry

    Article • Frontiers in Immunology, May 2026, Frontiers

    Emre Bilgin

  6. Agreement between large language models, human reviewers, and authors in evaluating STROBE checklists for observational studies in rheumatology

    Article • EULAR Rheumatology Open, May 2026, Elsevier

    Emre Bilgin

  7. Efficacy, retention, and safety of baricitinib in real-life: HUR-BIO monocentric experience

    Article • Ulusal Romatoloji Dergisi, March 2026, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  8. Evaluation of physiotherapy and rehabilitation awareness of physicians working with rheumatological patients: The example of Türkiye

    Article • Ulusal Romatoloji Dergisi, March 2026, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  9. Building bridges for early-career rheumatologists in Türkiye: insights from the Turkish Society for Rheumatology—Young Rheumatologists

    Article • Rheumatology, February 2026, Oxford University Press (OUP)

    Emre Bilgin

  10. The joint-local renin–angiotensin system in rheumatoid arthritis and osteoarthritis: mechanistic evidence, disease-specific patterns, and translational perspectives

    Article • Rheumatology International, February 2026, Springer Science + Business Media

    Emre Bilgin

  11. Turkish Society for Rheumatology recommendations for the diagnosis, follow-up and management of giant cell arteritis

    Article • Clinical and Experimental Rheumatology, December 2025, Clinical and Experimental Rheumatology

    Emre Bilgin

  12. Key factors contributing to gender inequity in global rheumatology awards: a global survey analysis

    Article • Rheumatology, November 2025, Oxford University Press (OUP)

    Dr Vikas Gupta, Emre Bilgin

  13. Risk of major organ involvement in Behçet’s patients with mucocutaneous onset: data from the AIDA Network Registry

    Article • Rheumatology, November 2025, Oxford University Press (OUP)

    Emre Bilgin, Dr Matteo Piga

  14. The Risk of Developing Ocular Involvement Among Behçet’s Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet’s Disease Registry

    Article • Ophthalmology and Therapy, November 2025, Springer Science + Business Media

    Emre Bilgin, Dr Matteo Piga

  15. Sleep quality and blood pressure variability after anti-TNF-α treatment in axial spondyloarthritis patients: A prospective preliminary study

    Article • Ulusal Romatoloji Dergisi, October 2025, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  16. Glucagon-Like Peptide-1 (GLP-1) receptor agonists in rheumatology: A review of current evidence and future directions

    Article • Autoimmunity Reviews, August 2025, Elsevier

    Emre Bilgin

  17. Educational and skill development needs of early-career rheumatologists in Türkiye

    Article • Ulusal Romatoloji Dergisi, July 2025, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  18. Central nervous system demyelination associated with biological agents used in the treatment of rheumatologic diseases: a retrospective cohort study

    Article • Neurological Sciences, July 2025, Springer Science + Business Media

    Emre Bilgin

  19. Behçet's disease beyond the criteria: insights from a tertiary centre in Turkey

    Article • Clinical and Experimental Rheumatology, June 2025, Clinical and Experimental Rheumatology

    Emre Bilgin

  20. Measuring what matters! The role of AAV-PRO in patient-centered care for EGPA: insights from the study by Delvino et al.

    Article • Rheumatology, June 2025, Oxford University Press (OUP)

    Emre Bilgin

  21. Current application, possibilities, and challenges of artificial intelligence in the management of rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis

    Article • Therapeutic Advances in Musculoskeletal Disease, June 2025, SAGE Publications

    Emre Bilgin

  22. QuantiFERON-TB Gold Plus for screening and monitoring latent tuberculosis infection in spondyloarthritis patients

    Article • The Journal of Infection in Developing Countries, May 2025, Journal of Infection in Developing Countries

    Emre Bilgin

  23. From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis Treatment in Turkey

    Article • Biologics Targets and Therapy, May 2025, Taylor & Francis

    Emre Bilgin

  24. Exploring the 'risk': Comments on the FAERS data regarding the safety of JAK inhibitors by Mikaeili et al.

    Article • Clinical and Experimental Rheumatology, April 2025, Clinical and Experimental Rheumatology

    Emre Bilgin

  25. Comments on the article by Goldman et al.

    Article • Seminars in Arthritis and Rheumatism, February 2025, Elsevier

    Emre Bilgin

  26. Beyond being a rheumatologist: Environment, climate change, and carbon footprint – We need an action!

    Article • Autoimmunity Reviews, February 2025, Elsevier

    Emre Bilgin

  27. ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis

    Article • Clinical Rheumatology, January 2025, Springer Science + Business Media

    Emre Bilgin

  28. Ethical challenges and regulatory pathways for artificial intelligence in rheumatology

    Article • Rheumatology Advances in Practice, January 2025, Oxford University Press (OUP)

    Emre Bilgin

  29. Comments and perspectives on the TREAT EARLIER study

    Article • Clinical and Experimental Rheumatology, December 2024, Clinical and Experimental Rheumatology

    Emre Bilgin

  30. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study

    Article • Clinical and Experimental Rheumatology, December 2024, Clinical and Experimental Rheumatology

    Emre Bilgin

  31. A nationwide study: prevalence of rheumatoid factor and anti- citrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, October 2024, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  32. Correction: Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

    Article • Internal and Emergency Medicine, May 2024, Springer Science + Business Media

    Emre Bilgin

  33. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

    Article • Internal and Emergency Medicine, March 2024, Springer Science + Business Media

    Emre Bilgin

  34. Unveiling Cancer Risk in ANCA-Associated Vasculitis: Result from the Turkish Vasculitis Study  Group (TRVaS)

    Article • January 2024, Springer Science + Business Media

    Emre Bilgin

  35. Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists. Second reply

    Article • Rheumatology, December 2023, Oxford University Press (OUP)

    Emre Bilgin

  36. Craniocervical junction involvement in inflammatory arthritis: a single-center radiologic study

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, December 2023, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  37. Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates

    Article • International Journal of Rheumatic Diseases, December 2023, Wiley

    Emre Bilgin

  38. Adapting HUVAC Vasculitis Registry to a Country-wide online registry system: Turkish Vasculitis Study Group Prospective Database, TRVaS

    Article • Acta Medica, October 2023, Hacettepe University - Medical School

    Emre Bilgin

  39. Costovertebral and costotransverse joint involvement in spondyloarthritis

    Article • International Journal of Rheumatic Diseases, August 2023, Wiley

    Emre Bilgin

  40. Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply

    Article • Rheumatology, August 2023, Oxford University Press (OUP)

    Emre Bilgin

  41. The predictors of paradoxical reactions, especially psoriasis, to biologic therapy—findings from the TReasure database: a 5-year follow-up study

    Article • Rheumatology, June 2023, Oxford University Press (OUP)

    Emre Bilgin

  42. AI am a rheumatologist: a practical primer to large language models for rheumatologists

    Article • Rheumatology, June 2023, Oxford University Press (OUP)

    Emre Bilgin

  43. Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

    Article • Rheumatology and Therapy, June 2023, Springer Science + Business Media

    Emre Bilgin

  44. Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?

    Article • Rheumatology International, April 2023, Springer Science + Business Media

    Emre Bilgin

  45. Comparison of lupus nephritis and non-lupus nephritides in patients with systemic lupus erythematosus

    Article • Ulusal Romatoloji Dergisi, March 2023, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  46. Derivation and validation of adult Still Activity Score (SAS)

    Article • Joint Bone Spine, January 2023, Elsevier

    Emre Bilgin

  47. Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone

    Article • Scandinavian Journal of Rheumatology, December 2022, Taylor & Francis

    Emre Bilgin

  48. Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database

    Article • Archives of Rheumatology, December 2022, AVES Publishing Co.

    Emre Bilgin

  49. Autoinflammation in psoriatic arthritis: time to better define the multifaceted enemy

    Article • RMD Open, November 2022, BMJ

    Emre Bilgin

  50. Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis

    Article • Rheumatology International, September 2022, Springer Science + Business Media

    Emre Bilgin

  51. Predicting the response to bDMARD treatment in RA: Then what?

    Article • Ulusal Romatoloji Dergisi, August 2022, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  52. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience

    Article • Lupus, June 2022, SAGE Publications

    Emre Bilgin

  53. Comparison of cardiovascular, cancer and herpes zoster risk of tofacitinib versus etanercept: single-centre observational study

    Article • Rheumatology, April 2022, Oxford University Press (OUP)

    Emre Bilgin

  54. Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results

    Article • Clinical Rheumatology, January 2022, Springer Science + Business Media

    Emre Bilgin

  55. Extremely high erythrocyte sedimentation rate revisited in rheumatic diseases: a singlecenter experience

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, January 2022, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  56. Can we predict transition from psoriasis to psoriatic arthritis?

    Article • Ulusal Romatoloji Dergisi, December 2021, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  57. The influence of obesity on biological agents treatment response in psoriatic arthritis: HUR-BIO real life results

    Article • Ulusal Romatoloji Dergisi, December 2021, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  58. From asymptomatic to critical illness: decoding various clinical stages of COVID-19

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, December 2021, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  59. Conventional Synthetic Dmards in Psoriatic Arthritis: Changing Practice in Biologic Era; Real-Life Results from HURBIO-PsA Registry

    Article • Acta Medica, November 2021, Hacettepe University - Medical School

    Emre Bilgin

  60. The clinical features and treatment of eosinophilic granulomatosis with polyangiitis (EGPA) in Turkey: one or two distinct diseases?

    Article • Internal and Emergency Medicine, October 2021, Springer Science + Business Media

    Emre Bilgin

  61. Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data

    Article • Clinical and Experimental Rheumatology, October 2021, Clinical and Experimental Rheumatology

    Emre Bilgin

  62. Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data

    Article • September 2021, Springer Science + Business Media

    Emre Bilgin

  63. The frequency of Achilles and plantar calcaneal spurs in gout patients

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, August 2021, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  64. Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, August 2021, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  65. c-ANCA positivity in a patient with relapsing polychondritis: Co-incidence or not? A case and review of the literature

    Article • Ulusal Romatoloji Dergisi, August 2021, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  66. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

    Article • Rheumatology International, July 2021, Springer Science + Business Media

    Emre Bilgin

  67. Iliac artery aneurysm in Behçet’s syndrome: collaborative management is essential

    Article • Rheumatology, June 2021, Oxford University Press (OUP)

    Emre Bilgin

  68. Journey of Vasculitis at Hacettepe University: from the Establishment of University to the Hacettepe AAV Workshop, 2020

    Article • Acta Medica, April 2021, Hacettepe University - Medical School

    Emre Bilgin

  69. Successful treatment of penile Mondor’s disease with infliximab in a patient with Behçet’s disease

    Article • Rheumatology, April 2021, Oxford University Press (OUP)

    Emre Bilgin

  70. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis

    Article • British Journal of Dermatology, April 2021, Wiley

    Emre Bilgin

  71. Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, February 2021, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  72. PILE: a candidate prognostic score in cancer patients treated with immunotherapy

    Article • Revista de Oncología, February 2021, Springer Science + Business Media

    Emre Bilgin

  73. Proposal of a new nomenclature for the underlying pathogenetic mechanism of severe Coronavirus Disease-19: “Inflammatory Thrombosis with Immune Endotheliitis—ITIE”

    Article • Rheumatology International, January 2021, Springer Science + Business Media

    Emre Bilgin

  74. Mediastinal mass in a patient with rheumatoid arthritis: lymphoid cystic thymic hyperplasia

    Article • Rheumatology Advances in Practice, January 2021, Oxford University Press (OUP)

    Emre Bilgin

  75. Clinical Characteristics and Outcome of ANCA-Associated Vasculitis; Experience of A Single Reference Vasculitis Center

    Article • Acta Medica, December 2020, Hacettepe University - Medical School

    Emre Bilgin

  76. Spinal and cerebral hematoma in systemic lupus erythematosus and antiphospholipid syndrome: is drug interaction the culprit?

    Article • Drug Metabolism and Drug Interactions, December 2020, De Gruyter

    Emre Bilgin

  77. Treatment modalities in psoriatic arthritis

    Article • Ulusal Romatoloji Dergisi, December 2020, Journal of Clinical Research of Pediatric Endocrinology

    Emre Bilgin

  78. Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: a systematic literature review of individual patients’ data

    Article • TURKISH JOURNAL OF MEDICAL SCIENCES, April 2020, The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS

    Emre Bilgin

  79. Temporomandibular disorders in ankylosing spondylitis: a cross-sectional, monocentric study

    Article • Rheumatology International, April 2020, Springer Science + Business Media

    Emre Bilgin

  80. Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis

    Article • Annals of the Rheumatic Diseases, February 2020, BMJ

    Emre Bilgin

  81. Comparison of Diagnostic Subgroup Survivals of Patients Who Admitted for Fever of Unknown Etiology Evaluation: Long-term Results of Single-centre, Prospective Study

    Article • Flora the Journal of Infectious Diseases and Clinical Microbiology, September 2019, Bilimsel Tip Publishing House

    Emre Bilgin

  82. Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

    Article • BMC Public Health, May 2019, Springer Science + Business Media

    Dr Javier Diez-Domingo, Emre Bilgin

  83. Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia

    Article • Rheumatology International, April 2019, Springer Science + Business Media

    Emre Bilgin

  84. Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial

    Article • Rheumatology, February 2019, Oxford University Press (OUP)

    Emre Bilgin

  85. Correction to: Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study

    Article • Clinical Rheumatology, February 2019, Springer Science + Business Media

    Emre Bilgin

  86. Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study

    Article • Clinical Rheumatology, February 2019, Springer Science + Business Media

    Emre Bilgin

  87. Some concerns from Turkey

    Article • Annals of the Rheumatic Diseases, November 2018, BMJ

    Emre Bilgin

  88. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature

    Article • Drug Metabolism and Personalized Therapy, June 2018, De Gruyter

    Emre Bilgin

  89. Blood group ‘A’ may have a possible modifier effect on familial Mediterranean fever and blood group ‘0’ may be associated with colchicine resistance

    Article • Biomarkers in Medicine, June 2018, Future Medicine

    Emre Bilgin

  90. Aspergillus Pneumonia in a Patient With Adult-Onset Still Disease Successfully Treated With Anakinra

    Article • JCR Journal of Clinical Rheumatology, April 2018, Wolters Kluwer Health

    Emre Bilgin

  91. Familial Mediterranean fever: New insights into cancer immunoprevention?

    Article • Arthritis & Rheumatology, March 2018, Wiley

    Emre Bilgin

  92. Increased psoriasis frequency in patients with familial Mediterranean fever

    Article • Upsala Journal of Medical Sciences, January 2018, Taylor & Francis

    Dr abdulsamet erden, Hafize Emine Sönmez, Emre Bilgin, Ezgi Deniz Batu

  93. The association of various social capital indicators and physical activity participation among Turkish adolescents

    Article • Journal of Sport and Health Science, January 2018, Elsevier

    Emre Bilgin

  94. Poor outcomes among elderly patients hospitalized for influenza-like illness

    Article • Current Medical Research and Opinion, October 2017, Taylor & Francis

    Emre Bilgin

  95. Increased cancer risk in patients with periodontitis

    Article • Current Medical Research and Opinion, August 2017, Taylor & Francis

    Emre Bilgin

  96. Comparing polyarteritis nodosa in children and adults: a single center study

    Article • International Journal of Rheumatic Diseases, June 2017, Wiley

    Hafize Emine Sönmez, Emre Bilgin

  97. Amniotic Membrane Transplantation for Spontaneous Corneal Perforation in a Case Of Rheumatoid Arthritis

    Article • Turkiye Klinikleri Journal of Ophthalmology, January 2017, Ortadogu Reklam Tanitim Yayincilik Turizm Egitim Insaat Sanayi ve Ticaret A.S.

    Emre Bilgin

  98. Behçet Disease With Vascular Involvement

    Article • Medicine, February 2015, Wolters Kluwer Health

    Emre Bilgin